Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kimberleigh Lillard"'
Autor:
Mikail Dogan, Lina Kozhaya, Lindsey Placek, Courtney Gunter, Mesut Yigit, Rachel Hardy, Matthew Plassmeyer, Paige Coatney, Kimberleigh Lillard, Zaheer Bukhari, Michael Kleinberg, Chelsea Hayes, Moshe Arditi, Ellen Klapper, Noah Merin, Bruce Tsan-Tang Liang, Raavi Gupta, Oral Alpan, Derya Unutmaz
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Using SARS-CoV-2-specific antibody- and neutralization assays, Dogan et al find that hospitalized individuals show higher IgG antibody responses and higher neutralization titers compared to outpatient or convalescent plasma donors, providing insights
Externí odkaz:
https://doaj.org/article/0a236342fbca4be7ad7450120dc25e6b
Autor:
Teresa H. Evering, Tina Vaziri, Alina P.S. Pang, Paige Coatney, Raavi Gupta, Zaheer Bukhari, Suzan Michalsky, Søren Ulrik Sønder, Thomas A. Premeaux, Lishomwa C. Ndhlovu, Nicole Rindone, Oral Alpan, Philip A. Mudd, Martin Latterich, Stephen T. Yeung, Gail Naughton, Denise Loizou, Alfred Spada, Michael J. Corley, Matthew Plassmeyer, Kimberleigh Lillard
Publikováno v:
Allergy
Background COVID‐19 can present with lymphopenia and extraordinary complex multiorgan pathologies that can trigger long‐term sequela. Aims Given that inflammasome products, like caspase‐1, play a role in the pathophysiology of a number of co‐
Autor:
Oral Alpan, Philip A. Mudd, Suzan Michalsky, Thomas A. Premeaux, Teresa H. Evering, Gail Naughton, Lishomwa C. Ndhlovu, Martin Latterich, Zaheer Bukhari, Tina Vaziri, Nicole Rindone, Alina P.S. Pang, Denise Loizou, Matthew Plassmeyer, Stephen T. Yueng, Kimberleigh Lillard, Alfred Spada, Michael J. Corley, Paige Coatney, Raavi Gupta
Currently, there is no effective vaccine and only one FDA approved early-stage therapy against SARS-CoV-2 infection as an indication to prevent disease progression. Cellular caspases play a role in the pathophysiology of a number of disorders that th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac856609132531f2f560798e8690bdd8
https://doi.org/10.1101/2020.11.02.20223636
https://doi.org/10.1101/2020.11.02.20223636
Autor:
Mikail Dogan, Lina Kozhaya, Lindsey Placek, Courtney L. Gunter, Mesut Yigit, Rachel Hardy, Matt Plassmeyer, Paige Coatney, Kimberleigh Lillard, Zaheer Bukhari, Michael Kleinberg, Chelsea Hayes, Moshe Arditi, Ellen Klappper, Noah Merin, Bruce T Liang, Raavi Gupta, Oral Alpan, Derya Unutmaz
Development of antibody protection during SARS-CoV-2 (CoV-2) infection is a pressing question for public health and for vaccine development. We developed highly sensitive CoV-2-specific antibody and neutralization assays. CoV-2 Spike protein or Nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a988b39d3e572e931e0f8d5d518e2f
https://doi.org/10.1101/2020.07.07.20148106
https://doi.org/10.1101/2020.07.07.20148106